Salt of aliskiren with orotic acid

Details for Australian Patent Application No. 2007316878 (hide)

Owner Novartis AG

Inventors Stowasser, Frank; Reber, Jean-Louis

Agent Davies Collison Cave

Pub. Number AU-B-2007316878

PCT Pub. Number WO2008/055669

Priority 06123758.2 09.11.06 EP

Filing date 7 November 2007

Wipo publication date 15 May 2008

Acceptance publication date 14 July 2011

International Classifications

C07C 237/22 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

C07D 239/54 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/055669 Priority application(s): WO2008/055669

14 July 2011 Application Accepted

  Published as AU-B-2007316878

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007316899-System for marking a non-human biological object and for taking a sample of the biological object

2007316875-Carbamate, thiocarbamate or carbamide comprising a biomolecular moiety